BiologyCurrent Opinion in Virology
Broadly neutralizing antibodies against COVID-19
D. Zhou, J. Ren, et al.
Explore the cutting-edge research by Daming Zhou and colleagues on the challenges posed by SARS-CoV-2 mutations and the promise of broadly neutralizing monoclonal antibodies to maintain therapeutic efficacy. Discover how these innovative treatments can play a crucial role in combating COVID-19 variants.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
X. Chi, Y. Guo, et al.
Medicine and Health
A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection
L. M. Coria, J. M. Rodriguez, et al.
Medicine and Health
Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
M. Belik, P. Jalkanen, et al.
Medicine and Health
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
S. Marot, I. Malet, et al.
